ZURICH, March 30 (Reuters) - Novartis pulled bowel drug Zelnorm from U.S. shelves on Friday at the request of regulators because clinical trial data indicated a possible link to heart attacks and ...
ZURICH, March 30 (Reuters) - Novartis AG has pulled its bowel drug Zelnorm from the U.S. market at the request of regulators, after clinical trial data indicated a link to heart attacks and stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results